BRNS vs BROS · $38.2M cap vs P/E 105, rev $1.02B
Barinthus Biotherapeutics plc (BRNS) versus Dutch Bros Inc (BROS) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
Latest reported BROS revenue for 2026-06-30 was $1.02B. Net income was $53.5M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
BRNS currently screens at market cap $38.2M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Not investment advice. Open the BRNS and BROS stock pages for the full models.
Not investment advice.